Close

BofA Securities Downgrades 10X Genomics (TXG) to Underperform

July 15, 2022 6:05 AM EDT
Get Alerts TXG Hot Sheet
Price: $35.84 -1.65%

Rating Summary:
    7 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 5 | New: 0
Join SI Premium – FREE

BofA Securities analyst Derik de Bruin downgraded 10X Genomics (NASDAQ: TXG) from Neutral to Underperform with a price target of $35.00 (from $80.00).


For an analyst ratings summary and ratings history on 10X Genomics click here. For more ratings news on 10X Genomics click here.


Shares of 10X Genomics closed at $43.29 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades, Hot Downgrades